The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 324.00
Bid: 323.50
Ask: 324.50
Change: -2.50 (-0.77%)
Spread: 1.00 (0.309%)
Open: 326.50
High: 326.50
Low: 323.00
Prev. Close: 326.50
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading Update

9 Nov 2023 07:00

RNS Number : 8547S
Morgan Advanced Materials PLC
09 November 2023
 

 

 

Press Release

Morgan Advanced Materials plc

9 November 2023

 

Trading Update

Strong financial position, growth outlook unchanged

Morgan Advanced Materials plc, the global manufacturer of advanced carbon and ceramic materials for technically demanding applications, announces today its scheduled trading update for the first nine months to 30 September 2023.

Current Trading

Sales for the nine months to September 2023 were 2.4% higher for the Group, on an organic constant-currency basis, compared with the same period last year. Our recovery from the cyber incident we experienced at the start of the year has progressed as planned. By business unit, organic constant-currency sales performance for the nine months to September 2023, compared with the same period last year, were as follows:

 

Thermal Ceramics

+0.9%

Molten Metal Systems

-7.2%

Electrical Carbon

+6.5%

Seals and Bearings

-5.4%

Technical Ceramics

+7.7%

 

Outlook

Our outlook for full year organic revenue growth is unchanged at 2-4%. The group has continued to benefit from strong growth in its Semiconductor, Healthcare and Aerospace end-markets, offsetting weakness in European and China industrial markets. Seals & Bearings performance was influenced in part by phasing of armour orders.

Margins have continued to improve sequentially, despite an adverse movement in FX impacting the second half by circa £3m.

We continue to pursue opportunities to remove cost to ensure we enter 2024 with the right cost structure. Although uncertainty remains around some of our end markets, looking forward we expect continued margin improvement and good growth in H1 2024, especially given the cyber incident in the comparative period. In particular, we expect sustained growth in Semiconductor driven by demand for Silicon Carbide applications in power electronics.

 

Pete Raby, Chief Executive Officer, said:

"Our business is growing as anticipated, benefitting from our leading, differentiated positions in selected markets and despite the challenging environment, with inflation continuing to be more than offset by pricing.

Our Board remains committed to our financial framework. Investment in capacity for our faster growing segments is accelerating, and we continue to investigate inorganic investments as well as consider opportunities for enhanced returns to shareholders."

The full year results are expected to be released on 14 March 2024. A Capital Markets Event will be held during Q2 2024, with updates on progress in our faster growing markets, opportunities for efficiency improvement and investment plans.

 

For further enquiries:

Pete Raby

Morgan Advanced Materials plc

01753 837000

Richard Armitage

Nina Coad

Brunswick

0207 404 5959

 

1. Company-compiled summary of current analysts' forecasts for adjusted operating profit for 2023 is a range of £120.5 million to £125.0 million.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAPFPEEDDFFA
Date   Source Headline
14th Oct 20149:29 amRNSHolding(s) in Company
2nd Oct 201411:25 amRNSDirector/PDMR Shareholding
29th Sep 20147:00 amRNSBoard Change
23rd Sep 20149:42 amRNSHolding(s) in Company
22nd Aug 201410:59 amRNSHolding(s) in Company
18th Aug 201410:16 amRNSHalf Yearly Report
5th Aug 20149:53 amRNSUNIVERSITY OF MANCHESTER PARTNERS WITH MORGAN
1st Aug 20149:18 amRNS£15m Composites & Defence Systems Contract Award
31st Jul 20142:13 pmRNSDirector/PDMR Shareholding
23rd Jul 20147:00 amRNSHalf Year Results
18th Jul 20149:25 amRNSDirector Declaration
15th Jul 20147:00 amRNSAcquisition of Porextherm Dämmstoffe GmbH
14th Jul 20149:15 amRNSDirector Declaration
18th Jun 20148:16 amRNSChange of Directors' responsibilities
16th Jun 201412:01 pmRNSBlocklisting Interim Review
9th Jun 20143:10 pmRNSHolding(s) in Company
9th Jun 201412:28 pmRNSAcquisition of Porextherm Dämmstoffe GmbH
9th Jun 201410:39 amRNSDirector/PDMR Shareholding
9th May 20143:39 pmRNSResult of AGM
9th May 20147:00 amRNSInterim Management Statement
9th Apr 201410:42 amRNSDirector/PDMR Shareholding
7th Apr 20143:49 pmRNSDirector/PDMR Shareholding
2nd Apr 20145:03 pmRNSAnnual Financial Report
1st Apr 201410:40 amRNSDirector/PDMR Shareholding
31st Mar 20144:21 pmRNSDirector/PDMR Shareholding
28th Mar 201410:14 amRNSDirector/PDMR Shareholding
25th Mar 201411:59 amRNSDirector/PDMR Shareholding
25th Mar 20149:46 amRNSDirector/PDMR Shareholding
24th Mar 20145:05 pmRNSDirector/PDMR Shareholding
3rd Mar 20144:15 pmRNSDirector/PDMR Shareholding
3rd Mar 201412:27 pmRNSDirector/PDMR Shareholding
28th Feb 201412:57 pmRNSDirector/PDMR Shareholding
21st Feb 20142:18 pmRNSDirector/PDMR Shareholding
18th Feb 20149:21 amRNSHolding(s) in Company
13th Feb 20147:00 amRNSFull Year Results
7th Feb 201410:31 amRNSDirectorate Change
16th Dec 201310:42 amRNSBlocklisting Interim Review
10th Dec 20134:54 pmRNSDirector/PDMR Shareholding
9th Dec 201310:40 amRNSDirector/PDMR Shareholding
29th Nov 201311:00 amRNSTotal Voting Rights
21st Nov 20139:00 amRNSCapital Markets Day
20th Nov 20132:29 pmRNSIssue of Equity
14th Nov 20138:54 amRNSHolding(s) in Company
11th Nov 20137:00 amRNSInterim Management Statement
30th Oct 201310:00 amRNSScrip Dividend Price
28th Oct 20134:11 pmRNSHolding(s) in Company
25th Sep 20133:39 pmRNSHolding(s) in Company
12th Sep 20135:14 pmRNSHolding(s) in Company
12th Sep 20134:52 pmRNSHolding(s) in Company
12th Sep 20134:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.